{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:10Z","timestamp":1786119070482,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/ico.0b013e318181a84f","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T03:19:42Z","timestamp":1229397582000},"page":"89-92","source":"Crossref","is-referenced-by-count":33,"title":["Infliximab for the Treatment of Refractory Progressive Sterile Peripheral Ulcerative Keratitis Associated With Late Corneal Perforation: 3-Year Follow-Up"],"prefix":"10.1097","volume":"28","author":[{"given":"Silvia","family":"Odorcic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C","family":"Keystone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J K","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210204","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression.","volume":"91","author":"Foster","year":"1984","journal-title":"Ophthalmology"},{"key":"R2-21-20210204","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/MAJ.0b013e3180318fbc","article-title":"Tumor necrosis factor antagonists. Preliminary evidence for an emerging approach in the treatment of ocular inflammation.","volume":"27","author":"Theodossiadis","year":"2007","journal-title":"Retina"},{"key":"R3-21-20210204","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","article-title":"Tumor necrosis factor blockade with infliximab for refractory uveitis and scleritis.","volume":"111","author":"Murphy","year":"2004","journal-title":"Ophthalmology"},{"key":"R4-21-20210204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.rhu.0000249766.24780.95","article-title":"Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab.","volume":"12","author":"Atchia","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"R5-21-20210204","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.ico.0000154391.28254.1d","article-title":"Therapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximab.","volume":"24","author":"Thomas","year":"2005","journal-title":"Cornea"},{"key":"R6-21-20210204","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.ICL.0000092064.05514.04","article-title":"Recombinant human tumor necrosis factor receptor Fc fusion protein (Etanercept): experience as a therapy for sight-threatening scleritis and sterile corneal ulceration.","volume":"30","author":"Hernandez-Illas","year":"2004","journal-title":"Eye Contact Lens"},{"key":"R8-21-20210204","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight-threatening panuveitis in Behcets disease.","volume":"358","author":"Sfikakis","year":"2001","journal-title":"Lancet"},{"key":"R9-21-20210204","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(01)06677-6","article-title":"Effect of infliximab on threatening panuveitis in Behcets disease [letter].","volume":"358","author":"Munoz-Fernandez","year":"2001","journal-title":"Lancet"},{"key":"R10-21-20210204","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1529-0131(200106)45:3<252::AID-ART257>3.0.CO;2-5","article-title":"Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.","volume":"45","author":"Smith","year":"2001","journal-title":"Arthritis Care Res"},{"key":"R11-21-20210204","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.eye.6702797","article-title":"Peripheral ulcerative keratitis in pityriasis rubra pilaris.","volume":"21","author":"Paranjothy","year":"2007","journal-title":"Eye"},{"key":"R12-21-20210204","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/bjo.2006.113316","article-title":"Rituximab treatment for peripheral ulcerative keratitis associated with Wegeners granulomatosis.","volume":"91","author":"Freidlin","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R13-21-20210204","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/bjo.2005.075689","article-title":"Successful treatment of Wegeners granulomatosis associated scleritis with rituximab.","volume":"89","author":"Cheung","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R14-21-20210204","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/ard.2004.027128","article-title":"Successful therapy of refractory anterior scleritis in primary Sjogrens syndrome with rituximab.","volume":"64","author":"Ahmadi-Simab","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R15-21-20210204","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1572-0241.2003.07368.x","article-title":"Retinal vein thrombosis after infliximab (Remicade) treatment for Crohns disease.","volume":"98","author":"Puli","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R16-21-20210204","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archopht.123.7.903","article-title":"A prospective trial of infliximab therapy for refractory uveitis.","volume":"123","author":"Suhler","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R17-21-20210204","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1445-5994.2001.00039.x","article-title":"Early Australian experience with infliximab, a chimeric antibody against tumor necrosis factor-alpha, in the treatment of Crohns disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy?","volume":"31","author":"Mortimore","year":"2001","journal-title":"Intern Med J"},{"key":"R19-21-20210204","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. Systematic review and meta-analysis of rare harmful effects in randomized controlled trials.","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"R20-21-20210204","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1056\/NEJMc070728","article-title":"Pneumocystis pneumonia associated with infliximab in Japan.","volume":"357","author":"Harigai","year":"2007","journal-title":"N Engl J Med"},{"key":"R21-21-20210204","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure. Results of the anti-TNF therapy against congestive heart failure (ATTACH) trial.","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"R22-21-20210204","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4103\/0301-4738.31951","article-title":"Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker.","volume":"55","author":"Agarwal","year":"2007","journal-title":"Indian J Ophthalmol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ICO.0b013e318181a84f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:27:03Z","timestamp":1786037223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-200901000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318181a84f","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}